Discover 4,544 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,544
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Brewer ME, Augusta ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase2, Recruiting
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
for
Hepatocellular Carcinoma, Biliary Tract Cancer
Location: The Bronx NY, Philadelphia PA, Baltimore MD, Miami FL,
Sponsor: Replimune Inc.
Sex: All
Age: 18+
Code: NCT05733598
Phase2, Recruiting
CMV CTLs in Neonates With CMV Infection
for
Congenital Cytomegaloviral (CMV) Disease
Location: Valhalla NY, Columbus OH, St Louis MO, Los Angeles CA
Sponsor: New York Medical College
Sex: All
Age: 0
Code: NCT05564598
Phase2, Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Boston MA, New Haven CT, Stony Brook NY, Lake Sucess NY,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01351545
Recruiting
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Location: The Bronx NY, Dallas TX, Seattle WA, Portland OR,
Sponsor: Eureka Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04864054
Phase1, Phase2, Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Boston MA, Stony Brook NY, Mineola NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase3, Recruiting
Observational Study Protocol: LIVER-R
for
Hepatobiliary Cancers
Location: Halifax, Boston MA, White Plains NY, Philadelphia PA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06252753
Recruiting
Dialectical Behavior Therapy for Justice-Involved Veterans
for
Criminal Behavior, Criminal Recidivism,
Location: The Bronx NY, Aurora CO
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT05974553
Recruiting
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors